No shortage on file

CABAZITAXEL FOR INJECTION

SANDOZ CANADA INCORPORATED

Quick answers

Is there a shortage of CABAZITAXEL FOR INJECTION in Canada?

No. There is no current shortage of CABAZITAXEL FOR INJECTION 60MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

Checked by MedShort2026-11-12

DIN

02487500

Strength

60MG

Dosage Form

Solution

Route

Intravenous

Active Ingredient

CABAZITAXEL

See all CABAZITAXEL products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495937

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495910

250MG · DIN 02246533

1MG · DIN 02548968

ARSENIC TRIOXIDE FOR INJECTION

10MG · DIN 02513420

ATRACURIUM BESYLATE INJECTION

10MG · DIN 02236759